A Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single and Multiple Doses of RO7049389 in Healthy Volunteers and Chronic Hepatitis B Virus (HBV) Infected Participants

NCT02952924 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

192

Enrollment

INDUSTRY

Sponsor class

Conditions

Hepatitis B, Chronic

Interventions

DRUG: Midazolam
OTHER: Placebo
DRUG: RO7049389

Sponsor

Hoffmann-La Roche